07:00 , Apr 7, 2008 |  BC Week In Review  |  Company News

Advanced Targeting Systems Inc., Cato Research neurology news

Cato and Advanced Targeting formed a JV called Advanced Pain Therapeutics LLC to develop and commercialize Advanced Targeting's Substance P- Saporin (SP-SAP) to treat chronic pain. The chemical conjugate of neurokinin 1 (NK1, substance P)...
08:00 , Nov 22, 1999 |  BC Week In Review  |  Company News

Advanced Targeting Systems Inc. other research news

Advanced Targeting researchers and colleagues published in Science that responses to chronic neuropathic and inflammatory pain were reduced in rats treated intrathecally with the company's conjugate between the Substance P neurotransmitter and the ribosome-inactivating toxin...
08:00 , Nov 1, 1999 |  BC Week In Review  |  Clinical News

Advanced Targeting Systems Inc. preclinical data

Advanced Targeting presented data showing that the company's conjugate between the Substance P neurotransmitter and the ribosome-inactivating toxin saporin selectively killed neurons involved in chronic pain in rats when injected into the fluid surrounding the...